Results 121 to 130 of about 4,885,439 (330)

MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Molecular biology and evolution, 2011
K. Tamura, D. Peterson, N. Peterson, G. Stecher, M. Nei, Sudhir Kumar   +5 more
semanticscholar   +1 more source

Inhibiting stearoyl‐CoA desaturase suppresses bone metastatic prostate cancer by modulating cellular stress, mTOR signaling, and DNA damage response

FEBS Letters, EarlyView.
Bone metastasis in prostate cancer (PCa) patients is a clinical hurdle due to the poor understanding of the supportive bone microenvironment. Here, we identify stearoyl‐CoA desaturase (SCD) as a tumor‐promoting enzyme and potential therapeutic target in bone metastatic PCa.
Alexis Wilson, Mackenzie K Herroon, Shane Mecca, Laimar C Garmo, Jacob Lindquist, Shrila Rajendran, Steve M. Patrick, Izabela Podgorski   +7 more
wiley   +1 more source

Fragile States: A Case Study Exploring Genetics, Molecular Biology, and Biochemistry Through the Lens of Fragile X Syndrome

, 2023
Amy T. Hark, Lauren E. Washco
openalex   +2 more sources

MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.

Molecular biology and evolution, 2013
K. Tamura, G. Stecher, D. Peterson, A. Filipski, Sudhir Kumar   +4 more
semanticscholar   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management

, 2009
Henry T. Lynch, Murray Joseph Casey, Carrie Snyder, Chhanda Bewtra, Jane F. Lynch, Matthew D. Butts, Andrew K. Godwin   +6 more
openalex   +2 more sources

Supplementary Material for: The Genetics Analysis of Molecular Pathogenesis for Alzheimer's Disease

, 2020
Guan Ning Lin, Kangming Ji, Shun Li, Wujun Ma, Xiaoyong Pan   +4 more
openalex   +1 more source

Molecular genetics of blood‐fleshed peach reveals activation of anthocyanin biosynthesis by NAC transcription factors [PDF]

, 2015
Hui Zhou, Kui Lin‐Wang, Huiliang Wang, Chao Gu, Andrew P. Dare, Richard V. Espley, Huaping He, Andrew C. Allan, Yuepeng Han   +8 more
openalex   +1 more source

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.

Molecular biology and evolution, 2007
K. Tamura, J. Dudley, M. Nei, Sudhir Kumar   +3 more
semanticscholar   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source